FI971711A0 - Levobupivakaiinin ja sen analogien kiteyttäminen - Google Patents
Levobupivakaiinin ja sen analogien kiteyttäminenInfo
- Publication number
- FI971711A0 FI971711A0 FI971711A FI971711A FI971711A0 FI 971711 A0 FI971711 A0 FI 971711A0 FI 971711 A FI971711 A FI 971711A FI 971711 A FI971711 A FI 971711A FI 971711 A0 FI971711 A0 FI 971711A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- levobupivacaine
- analogues
- crystallization
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
- Epoxy Compounds (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9421476A GB9421476D0 (en) | 1994-10-25 | 1994-10-25 | Process and salt |
| GB9421476 | 1994-10-25 | ||
| GB9504926 | 1995-03-10 | ||
| GBGB9504926.8A GB9504926D0 (en) | 1995-03-10 | 1995-03-10 | Crystallisation |
| GB9502513 | 1995-10-23 | ||
| PCT/GB1995/002513 WO1996012699A1 (en) | 1994-10-25 | 1995-10-23 | Crystallisation of levobupivacaine and analogues thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI971711A0 true FI971711A0 (fi) | 1997-04-22 |
| FI971711A FI971711A (fi) | 1997-04-22 |
| FI117438B FI117438B (fi) | 2006-10-13 |
Family
ID=26305863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI971711A FI117438B (fi) | 1994-10-25 | 1997-04-22 | Menetelmä optisesti rikastetun bupivakaiinin valmistamiseksi |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5994548A (fi) |
| EP (1) | EP0788480B1 (fi) |
| JP (1) | JP3911545B2 (fi) |
| AT (1) | ATE245629T1 (fi) |
| AU (1) | AU698637B2 (fi) |
| CA (1) | CA2200355C (fi) |
| DE (1) | DE69531356T2 (fi) |
| DK (1) | DK0788480T3 (fi) |
| ES (1) | ES2202375T3 (fi) |
| FI (1) | FI117438B (fi) |
| HU (1) | HU227420B1 (fi) |
| MX (1) | MX9703024A (fi) |
| NO (1) | NO309266B1 (fi) |
| PL (1) | PL183210B1 (fi) |
| PT (1) | PT788480E (fi) |
| WO (1) | WO1996012699A1 (fi) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0002246A (pt) * | 2000-04-06 | 2003-04-15 | Cristalia Prod Quimicos Farm | Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis |
| BRPI0104491B8 (pt) * | 2001-10-10 | 2021-05-25 | Cristalia Produtos Quim Farmaceuticos Ltda | n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica. |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| EP2218448B1 (en) | 2002-12-13 | 2015-09-23 | Durect Corporation | Oral drug delivery system comprising high viscosity liquid carrier materials |
| US6790267B1 (en) * | 2003-04-24 | 2004-09-14 | Xerox Corporation | Colorant compositions |
| US7094812B2 (en) * | 2003-04-24 | 2006-08-22 | Xerox Corporations | Colorant compositions |
| CA2581287C (en) | 2004-09-17 | 2015-08-25 | Durect Corporation | Sustained local anesthetic composition containing bupivacaine and saib |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| JP2009535327A (ja) * | 2006-04-25 | 2009-10-01 | ディシュマン・ファーマシューティカルズ・アンド・ケミカルズ・リミテッド | ロピバカイン塩酸塩無水物およびその調製 |
| AU2007325918B2 (en) | 2006-11-03 | 2013-10-17 | Durect Corporation | Transdermal delivery systems comprising bupivacaine |
| JP2011506319A (ja) | 2007-12-06 | 2011-03-03 | デュレクト コーポレーション | 疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法 |
| EP2234974B1 (en) * | 2008-01-15 | 2012-04-25 | Pharmathen S.A. | Process for the preparation of (s)-1-alkyl-2',6'-pipecoloxylidide compound |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| CN103073484B (zh) * | 2013-01-28 | 2014-10-22 | 山东诚创医药技术开发有限公司 | 一种甲哌卡因及其光学对映体的制备方法 |
| AU2014233453A1 (en) | 2013-03-15 | 2015-10-01 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| RU2021114918A (ru) * | 2016-12-26 | 2021-07-09 | Целликс Био Прайвет Лимитед | Композиции и способы лечения хронической боли |
| BR112022013784A2 (pt) | 2020-01-13 | 2022-10-11 | Durect Corp | Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE341404B (fi) * | 1967-05-18 | 1971-12-27 | Sterling Drug Inc | |
| US4695576A (en) * | 1984-07-09 | 1987-09-22 | Astra Lake Medel Aktiebolag | L-N-n-propylpipecolic acid-2,6-xylidide |
-
1995
- 1995-10-23 DE DE69531356T patent/DE69531356T2/de not_active Expired - Lifetime
- 1995-10-23 AU AU37048/95A patent/AU698637B2/en not_active Expired
- 1995-10-23 WO PCT/GB1995/002513 patent/WO1996012699A1/en active IP Right Grant
- 1995-10-23 ES ES95934738T patent/ES2202375T3/es not_active Expired - Lifetime
- 1995-10-23 HU HU9702372A patent/HU227420B1/hu unknown
- 1995-10-23 US US08/849,418 patent/US5994548A/en not_active Expired - Lifetime
- 1995-10-23 AT AT95934738T patent/ATE245629T1/de active
- 1995-10-23 MX MX9703024A patent/MX9703024A/es unknown
- 1995-10-23 PT PT95934738T patent/PT788480E/pt unknown
- 1995-10-23 DK DK95934738T patent/DK0788480T3/da active
- 1995-10-23 PL PL95319829A patent/PL183210B1/pl unknown
- 1995-10-23 JP JP51373896A patent/JP3911545B2/ja not_active Expired - Lifetime
- 1995-10-23 EP EP95934738A patent/EP0788480B1/en not_active Expired - Lifetime
- 1995-10-23 CA CA002200355A patent/CA2200355C/en not_active Expired - Lifetime
-
1997
- 1997-04-22 FI FI971711A patent/FI117438B/fi not_active IP Right Cessation
- 1997-04-24 NO NO971903A patent/NO309266B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT788480E (pt) | 2003-12-31 |
| DK0788480T3 (da) | 2003-09-29 |
| ATE245629T1 (de) | 2003-08-15 |
| US5994548A (en) | 1999-11-30 |
| AU3704895A (en) | 1996-05-15 |
| NO309266B1 (no) | 2001-01-08 |
| PL319829A1 (en) | 1997-09-01 |
| FI117438B (fi) | 2006-10-13 |
| PL183210B1 (pl) | 2002-06-28 |
| NO971903D0 (no) | 1997-04-24 |
| EP0788480B1 (en) | 2003-07-23 |
| DE69531356D1 (de) | 2003-08-28 |
| EP0788480A1 (en) | 1997-08-13 |
| WO1996012699A1 (en) | 1996-05-02 |
| AU698637B2 (en) | 1998-11-05 |
| NO971903L (no) | 1997-04-24 |
| JPH10507464A (ja) | 1998-07-21 |
| ES2202375T3 (es) | 2004-04-01 |
| DE69531356T2 (de) | 2004-05-27 |
| HUT77631A (hu) | 1998-06-29 |
| CA2200355A1 (en) | 1996-05-02 |
| FI971711A (fi) | 1997-04-22 |
| HU227420B1 (en) | 2011-05-30 |
| CA2200355C (en) | 2007-03-06 |
| JP3911545B2 (ja) | 2007-05-09 |
| MX9703024A (es) | 1997-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI971711A0 (fi) | Levobupivakaiinin ja sen analogien kiteyttäminen | |
| NO965119D0 (no) | Steriliseringsmiddel for værelsestemperatur | |
| DE69406522D1 (de) | Verfahren zur Herstellung von alkalilöslichen Emulsionscopolymeren | |
| DE69109401T2 (de) | Wässrige Zusammensetzungen zur Behandlung von porösen Substraten. | |
| DE69403210T2 (de) | Verfahren zur herstellung von n-acetylneuraminsäure | |
| FI951511A0 (fi) | IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon | |
| DE58907083D1 (de) | Verfahren zur Herstellung von Benztriazolderivaten. | |
| DK0476113T3 (da) | Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose | |
| ATE69795T1 (de) | Verfahren zur herstellung von ethylenischen carbonylverbindungen. | |
| DE59407675D1 (de) | Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on | |
| DE69210069T2 (de) | Verfahren zur Herstellung von 1,3-Dioxolen | |
| DE69210933T2 (de) | Verfahren zur Herstellung von Alpha, Omega-Dihydroxyperfluoroalkylethylmethylpolysiloxanen | |
| ES2162078T3 (es) | Compuestos terapeuticos. | |
| DE69103913D1 (de) | Verfahren zur Herstellung von Dodekandicarbonsäure. | |
| DE59204060D1 (de) | Verfahren zur Herstellung von 1-Fluor-cyclopropan-1-carbonsäure. | |
| DE68913394T2 (de) | Verfahren zur Herstellung von substituierten Phenoxyethylaminen sowie Zwischenverbindungen. | |
| DE69019843T2 (de) | Verfahren zur Herstellung von NADH-Oxydase. | |
| DE59200254D1 (de) | Verfahren zur Herstellung von N-(Hydroxyalkyl)-carbamidsäure- alkylestern. | |
| DE58909337D1 (de) | Verfahren zur Herstellung von reinen 3-Butenyltriorganyloxysilanen. | |
| ATE128188T1 (de) | Menschliches gamma-interferon, verfahren zu seiner herstellung und seine verwendung. | |
| DE69103294D1 (de) | Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten. | |
| ES2065843B1 (es) | Aplicacion de ent-11 , 16-dihidroxi-18-nor-4a -carboximetil-oxido de manoilo como inhibidor de la adenilatociclasa. | |
| DE59105754D1 (de) | Verfahren zur Herstellung von beta-Resorcylsäurederivaten. | |
| DE59401794D1 (de) | Verfahren zur Herstellung von 2,4-Pyridindicarbonsäure | |
| DE69405698T2 (de) | Verfahren zur Herstellung von 4-Methoxy-2,2',6'-Trimethyldiphenylamin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 117438 Country of ref document: FI |
|
| MA | Patent expired |